Hint mode is switched on Switch off

EyePoint Pharmaceuticals, ordinary share
EYPT, US30233G2093

Add a stock to WL
Choose all Reset all
EyePoint Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    EyePoint Pharmaceuticals Inc.
  • Industry
    Miscellaneous Healthcare: Products and Services

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    EYPT
  • Placement
    29.03.2019
  • Lock up period
    180
  • Number of papers
    10,526,500
  • Volume of raised funds
    20 mln USD
  • Placement share
    9.94%
  • Final placement price
    1.9 USD
  • Price change since placement date
    -100%
  • By capitalization
    201.21 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    EYPT
  • Placement
    02.02.2021
  • Lock up period
    180
  • Number of papers
    9,100,000
  • Volume of raised funds
    100.1 mln USD
  • Placement share
    33.35%
  • Final placement price
    11 USD
  • Price change since placement date
    -100%
  • By capitalization
    300.17 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    EYPT
  • Placement
    18.11.2021
  • Lock up period
    180
  • Number of papers
    4,027,273
  • Volume of raised funds
    55.38 mln USD
  • Placement share
    12.28%
  • Final placement price
    13.75 USD
  • Price change since placement date
    -100%
  • By capitalization
    450.98 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    EYPT
  • Placement
    07.12.2023
  • Lock up period
    180
  • Number of papers
    47,074,138
  • Volume of raised funds
    200 mln USD
  • Placement share
    24.99%
  • Final placement price
    17 USD
  • Price change since placement date
    -24.35%
  • By capitalization
    800.26 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    EYPT
  • Placement
    30.10.2024
  • Lock up period
    180
  • Number of papers
    12,727,273
  • Volume of raised funds
    140 mln USD
  • Placement share
    19.23%
  • Final placement price
    11 USD
  • Price change since placement date
    16.91%
  • By capitalization
    728.06 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Related Stock indices

Indicators

News

13/07/2026 EyePoint Pharmaceuticals: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
20/03/2026 EyePoint Pharmaceuticals: Regulation Fd Disclosure
08/12/2025 EyePoint Pharmaceuticals: Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
14/10/2025 EyePoint Pharmaceuticals: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibits
18/06/2025 EyePoint Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.